HIGHFDA DRUG

Teva Metoprolol Succinate 50 mg Extended-Release Recall 2026 Following Failed Dissolution Specs (67,

Teva Pharmaceuticals recalled 67,043 bottles of Metoprolol Succinate Extended-Release Tablets, 50 mg, distributed nationwide. The FDA enforcement report cites Failed Dissolution Specifications as the hazard. Health care providers and patients should stop using this product immediately and contact Teva for guidance.

Official notice
METOPROLOL SUCCINATEActavis Pharma, Inc.Health & Personal CareDrugs & MedicationsLot#: a) 0486G251, 0487G251, 0488G251; Exp.: 01/2027b) 0486G252, 0487G253, 0488G252; Exp.: 01/2027

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 29, 2026
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
January 29, 2026
Hazard Level
HIGH
Brands
METOPROLOL SUCCINATE, Actavis Pharma, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
METOPROLOL SUCCINATE, Actavis Pharma, Inc.
Product type
Extended-Release Tablet
Model numbers
Lot#: a) 0486G251, 0487G251, 0488G251; Exp.: 01/2027, b) 0486G252, 0487G253, 0488G252; Exp.: 01/2027
UPC codes
45963-676, 45963-709, 45963-677, 45963-678, 45963-709-11, 45963-709-96, 45963-676-11, 45963-676-96 +3 more
Sizes
100-tablet bottle, 1,000-tablet bottle
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 29, 2026

  2. Reported by FDA DRUG

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

About This Product

Metoprolol succinate extended-release tablets are used to treat high blood pressure and other heart-related conditions. They are prescribed and dispensed by healthcare professionals.

Why This Is Dangerous

The dissolution failure means the medicine may not release the active ingredient as designed, potentially reducing effectiveness or causing unpredictable effects.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

Patients may experience reduced therapeutic effect or unpredictable blood pressure control. The recall impacts a large nationwide distribution and requires immediate clinician guidance.

Practical Guidance

How to identify if yours is affected

  1. Check NDC: 45963-676-11 (100-tablet bottle) or 45963-676-96 (1,000-tablet bottle)
  2. Look for name Metoprolol Succinate Extended-Release 50 mg on the bottle

Where to find product info

NDC and lot numbers are on the bottle label near the bottom or back panel.

What timeline to expect

Recall status is active. No specific replacement timeline provided. Monitor Teva FDA notices for updates.

If the manufacturer is unresponsive

  • Ask your healthcare provider for guidance if Teva is unresponsive.
  • Consider contacting your pharmacist for alternatives and guidance on securing medication.

How to prevent similar issues

  • Verify NDC and lot numbers on any substituted product.
  • Only obtain prescription medications through licensed providers and pharmacies.
  • Ask for full counseling on any beta-blocker switch or substitution.

Documentation advice

Keep the recall notice, bottle labels, and all correspondence with Teva. Document dates, conversations, and any adverse effects.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDCs: 45963-676-11 (50 mg, 100-tablet bottles) and 45963-676-96 (50 mg, 1,000-tablet bottles). Sold nationwide. Rx Only. Manufacturer: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Quantity: 67,043 bottles. Price: Unknown. Model/Lot information: Lot numbers a) 0486G251, 0487G251, 0488G251; Exp. 01/2027. Lot numbers b) 0486G252, 0487G253, 0488G252; Exp. 01/2027.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
ELECTRICALLACERATIONPOISONINGSUFFOCATIONOTHER

Product Details

Model Numbers
Lot#: a) 0486G251, 0487G251, 0488G251; Exp.: 01/2027
b) 0486G252, 0487G253, 0488G252; Exp.: 01/2027
UPC Codes
45963-676
45963-709
45963-677
+8 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls